Drug Information Journal - March 2009 - (Page 103)

OFFICIAL PUBLICATION OF THE DRUG INFORMATION ASSOCIATION Michael R. Hamrell, PhD Editor-in-Chief June Almenoff, MD, PhD GlaxoSmithKline Joseph R. Assenzo, PhD Drug Information Association David Bristol, PhD Purdue Pharma, L.P. Joseph C. Cappelleri, PhD, MPH, MS Pfizer Inc Steven H. Chasin, PhD U.S. Food and Drug Administration Horsham · Pennsylvania Basel · Switzerland Tokyo · Japan Mumbai · India Table of Contents for the Digital Edition of Drug Information Journal - March 2009Drug Information Journal - March 2009Table of ContentsHow to Write a Better ManuscriptNew Web Tools to Improve PubMed Searches for the Biomedical CommunityA Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life CycleReusing Clinical Protocol Content to Improve R&D ProductivityLocal Laboratory Reference Intervals in Clinical TrialsEstablishing an Industry-Based Drug Information Pharmacy Student RotationKnowledge Innovation and Clinical Operational ExcellenceTrends in Meta-analysisA Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical TrialsSampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be ConsideredClinical Trial Registries: A Survey of Patient Advocate Group PerceptionsFactors Associated With Multiple FDA Review Cycles and Approval Phase Times2009 EuroMeeting Student Poster AbstractsDrug Information Journal - March 2009Drug Information Journal - March 2009 - (Page Intro)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page Cover1)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page Cover2)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 101)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 102)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 103)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 104)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 105)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 106)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 107)Drug Information Journal - March 2009 - Drug Information Journal - March 2009 (Page 108)Drug Information Journal - March 2009 - Table of Contents (Page 109)Drug Information Journal - March 2009 - Table of Contents (Page 110)Drug Information Journal - March 2009 - How to Write a Better Manuscript (Page 111)Drug Information Journal - March 2009 - How to Write a Better Manuscript (Page 112)Drug Information Journal - March 2009 - How to Write a Better Manuscript (Page 113)Drug Information Journal - March 2009 - How to Write a Better Manuscript (Page 114)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 115)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 116)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 117)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 118)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 119)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 120)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 121)Drug Information Journal - March 2009 - New Web Tools to Improve PubMed Searches for the Biomedical Community (Page 122)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 123)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 124)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 125)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 126)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 127)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 128)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 129)Drug Information Journal - March 2009 - A Pharmaceutical Alliance in Medical Information: Lessons Learned in the Life Cycle (Page 130)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 131)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 132)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 133)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 134)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 135)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 136)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 137)Drug Information Journal - March 2009 - Reusing Clinical Protocol Content to Improve R&D Productivity (Page 138)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 139)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 140)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 141)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 142)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 143)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 144)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 145)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 146)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 147)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 148)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 149)Drug Information Journal - March 2009 - Local Laboratory Reference Intervals in Clinical Trials (Page 150)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 151)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 152)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 153)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 154)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 155)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 156)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 157)Drug Information Journal - March 2009 - Establishing an Industry-Based Drug Information Pharmacy Student Rotation (Page 158)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 159)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 160)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 161)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 162)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 163)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 164)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 165)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 166)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 167)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 168)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 169)Drug Information Journal - March 2009 - Knowledge Innovation and Clinical Operational Excellence (Page 170)Drug Information Journal - March 2009 - Trends in Meta-analysis (Page 171)Drug Information Journal - March 2009 - Trends in Meta-analysis (Page 172)Drug Information Journal - March 2009 - Trends in Meta-analysis (Page 173)Drug Information Journal - March 2009 - Trends in Meta-analysis (Page 174)Drug Information Journal - March 2009 - Trends in Meta-analysis (Page 175)Drug Information Journal - March 2009 - Trends in Meta-analysis (Page 176)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 177)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 178)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 179)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 180)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 181)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 182)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 183)Drug Information Journal - March 2009 - A Multiple Comparisons Procedure for Comparing All Arms in Three-Arm Clinical Trials (Page 184)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 185)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 186)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 187)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 188)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 189)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 190)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 191)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 192)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 193)Drug Information Journal - March 2009 - Sampling Uncertainty in the Cost-Effectiveness Evaluations and Guidance Given by the Existing Pharmacoeconomic Guidelines: A Question to Be Considered (Page 194)Drug Information Journal - March 2009 - Clinical Trial Registries: A Survey of Patient Advocate Group Perceptions (Page 195)Drug Information Journal - March 2009 - Clinical Trial Registries: A Survey of Patient Advocate Group Perceptions (Page 196)Drug Information Journal - March 2009 - Clinical Trial Registries: A Survey of Patient Advocate Group Perceptions (Page 197)Drug Information Journal - March 2009 - Clinical Trial Registries: A Survey of Patient Advocate Group Perceptions (Page 198)Drug Information Journal - March 2009 - Clinical Trial Registries: A Survey of Patient Advocate Group Perceptions (Page 199)Drug Information Journal - March 2009 - Clinical Trial Registries: A Survey of Patient Advocate Group Perceptions (Page 200)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 201)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 202)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 203)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 204)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 205)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 206)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 207)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 208)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 209)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 210)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 211)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 212)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 213)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 214)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 215)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 216)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 217)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 218)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 219)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 220)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 221)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 222)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 223)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 224)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 225)Drug Information Journal - March 2009 - Factors Associated With Multiple FDA Review Cycles and Approval Phase Times (Page 226)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page 227)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page 228)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page 229)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page 230)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page 231)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page 232)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page Cover3)Drug Information Journal - March 2009 - 2009 EuroMeeting Student Poster Abstracts (Page Cover4)http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1109http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0909http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0709http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0509http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0309http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0109http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1108http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0908http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0708http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0508http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0308http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0108http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1107http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0907http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0707http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0507http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0307http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.